Aroa Biosurgery Ltd (AU:ARX) has released an update.
Dr. Catherine Mohr, a director of Aroa Biosurgery Limited, has increased her direct and indirect shareholdings through an on-market trade, acquiring 436,364 fully paid ordinary shares at a cost of $163,453.67. This transaction, dated September 30, 2024, brings Dr. Mohr’s total direct and indirect interest in the company to 647,050 shares, following her previously held 210,686 options exercisable at $0.87, set to expire on November 13, 2027.
For further insights into AU:ARX stock, check out TipRanks’ Stock Analysis page.